Panoramic Case Studies
Panoramic Health is supporting global enrollment for a Phase III trial in IgA nephropathy (IgAN), a rare kidney disease that often requires proactive patient identification to meet study goals. Given the trial’s modest global enrollment target, each site’s contribution carried significant weight.
The study aims to evaluate a novel investigational therapy in patients with IgAN. Panoramic Health’s role is to identify and enroll eligible patients across its network using its advanced data and analytics capabilities.
Using its enterprise-wide EMR system, Panoramic Health’s central enrollment team proactively identifies potential participants not only at designated research sites but also across affiliated office locations, broadening the pool of eligible patients. EMR-integrated eligibility flags signal treating physicians to refer candidates during routine visits, while dedicated research staff coordinate prescreening, consent, and enrollment to ensure a seamless patient experience.
By combining advanced analytics with a broad clinical footprint, Panoramic Health is delivering meaningful impact in a rare disease trial, reinforcing its ability to reach hard-to-enroll patients and contribute to study success.
Panoramic Health is kidney care’s leading integrated provider group, supporting a network of aligned nephrology practices across the U.S. treating hundreds of thousands of patients. Our mission is to slow disease progression and improve quality of life by empowering nephrologists with state-of-the-art clinical, operational, and financial solutions.
Founded by nephrologists, for nephrologists, Panoramic Health has a deep commitment to preserving clinical autonomy while supporting practice growth and reducing administrative burden. Our integrated model is built around the needs of complex kidney patients and enables partner practices to enhance care quality, reduce total cost of care, and access new revenue opportunities.